- Home
- ABSI vs NRC Comparison
ABSI vs NRC Comparison
Compare ABSI & NRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABSI
- NRC
- Stock Information
- Founded
- ABSI 2011
- NRC 1981
- Country
- ABSI United States
- NRC United States
- Employees
- ABSI N/A
- NRC N/A
- Industry
- ABSI Biotechnology: Pharmaceutical Preparations
- NRC Biotechnology: Commercial Physical & Biological Resarch
- Sector
- ABSI Health Care
- NRC Health Care
- Exchange
- ABSI Nasdaq
- NRC Nasdaq
- Market Cap
- ABSI 338.0M
- NRC 310.8M
- IPO Year
- ABSI 2021
- NRC N/A
- Fundamental
- Price
- ABSI $2.63
- NRC $15.37
- Analyst Decision
- ABSI Strong Buy
- NRC
- Analyst Count
- ABSI 5
- NRC 0
- Target Price
- ABSI $7.98
- NRC N/A
- AVG Volume (30 Days)
- ABSI 5.6M
- NRC 122.4K
- Earning Date
- ABSI 08-12-2025
- NRC 07-28-2025
- Dividend Yield
- ABSI N/A
- NRC 3.31%
- EPS Growth
- ABSI N/A
- NRC N/A
- EPS
- ABSI N/A
- NRC 0.77
- Revenue
- ABSI $4,138,000.00
- NRC $140,314,000.00
- Revenue This Year
- ABSI $74.53
- NRC N/A
- Revenue Next Year
- ABSI $296.01
- NRC N/A
- P/E Ratio
- ABSI N/A
- NRC $19.96
- Revenue Growth
- ABSI 27.32
- NRC N/A
- 52 Week Low
- ABSI $2.01
- NRC $9.76
- 52 Week High
- ABSI $6.33
- NRC $22.99
- Technical
- Relative Strength Index (RSI)
- ABSI 40.89
- NRC 53.66
- Support Level
- ABSI $2.49
- NRC $14.45
- Resistance Level
- ABSI $3.40
- NRC $16.21
- Average True Range (ATR)
- ABSI 0.19
- NRC 0.64
- MACD
- ABSI -0.05
- NRC 0.12
- Stochastic Oscillator
- ABSI 15.38
- NRC 66.47
About ABSI Absci Corporation
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process.
About NRC National Research Corporation (Delaware)
National Research Corp is a provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare providers, payers, and other healthcare organizations. Its portfolio of solutions represents a set of capabilities that individually and collectively provide value to clients. It operates in the United States and Canada, of which key revenue is derived from the United States.